Kayo, Takumi
Suzuki, Masao
Mitsuma, Tadamichi
Fukuda, Fumihiko
Article History
Received: 3 March 2023
Accepted: 13 January 2024
First Online: 20 January 2024
Declarations
:
: This study was a secondary analysis of data from the previous clinical trial [CitationRef removed], which was conducted in accordance with the Declaration of Helsinki and its amendments, as well as the Guidelines for Good Clinical Practice for Epidemiological Studies and Clinical Research issued by the Japanese Ministry of Health, Labour and Welfare, and the research protocol is registered in the UMIN Clinical Trials Registry (UMIN000001277). In the previous trial, written informed consent was obtained from all participants. This study used only the data collected from this previous trial. Therefore, we disclosed information about this study on our website and provided the participants with the chance to opt-out. The Research Ethics Committee of Meiji University of Integrative Medicine approved this study (Approval number 2021-016).
: Not applicable.
: TK, MS, and TM are supported with a grant from Seirin Corporation. TK, MS, TM, and FF are Advisory Board Member, Executive Director, Advisor, and Director of the Japan Society of Acupuncture and Moxibustion, respectively.